TechInvention reveals positive outcomes of its indigenously developed recombinant subunit SARS-CoV-2 vaccine
CoviTechTM vaccine may have the potential to address the burning issue of mutations, especially the ‘Variants of Concern’ (VOC) which has been hammering countries through subsequent waves of infection. TechInvention Lifecare Pvt. Ltd., a Biotech start-up company based out of Mumbai, India has revealed positive outcomes of its recombinant subunit SARS-CoV-2 vaccine (CoviTechTM) in a … Read more